The IVD market follows patients where technologies allow. There’s no greater evidence for need for IVD product makers to find a market in physician office labs than the declining hospital bed count. With declining hospital bed in developed countries and slow growth in hospital bed volume even in developing nations, it makes sense that more […]

The first NGS system was approved for clinical use by the FDA only in 2013. Hence, the market segment is quite new, even though a significant industry exists for LDTs performed as testing services on NGS platforms by certified clinical labs. The current IVD market available in clinical sequencing consists largely of sales of NGS […]

The market for medical devices is valued at $570 billion in 2022, according to Kalorama Information’s 12th report on the market since 2009. It grew 2.7% last year, and Kalorama believes it will grow average 3.4% next five years. Expect increasing revenue growth for 2022 as markets continue to stabilize. In 2023 and forward, growth […]

According to Kalorama Information’s 2022 molecular diagostics report [https://kaloramainformation.com/product/the-world-market-for-molecular-diagnostics-tests-11th-edition/], the market now exceed 21 billion. The demand for molecular IVD means that very often a single firm cannot go it alone and must find partners. These are partnerships involving 20 companies that have just occurred in recent months: Immucor and Pirche: a multi-year partnership to […]